• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

Expression Pathology Inc. (EPI)

Expression Pathology is advancing personalized medicine with assays that measure cancer signaling networks—at the functional protein level—in FFPE tissue to individualize and improve patient treatment decisions. Expression Pathology's patented Liquid Tissue®-SRM technology platform makes possible highly multiplexed protein quantitation by powerful mass spectrometry of minute amounts of laser microdissected FFPE tissue. Expression Pathology offers a broad menu of multiplexed SRM assays for major cancer signaling networks to advance development of targeted therapies and improve patient stratification. The assays include a range of drug target pathway proteins including EFGR, IGF-1R, cMET, Her3, cSRC, MEK, and their phosphorylation states, as well as many others. *

 

	Start	2003-07-11 existent
	Industry	tissue microarray
	Region	Rockville, MD
	Country	United States (USA)
	Street	9620 Medical Center Drive
	City	20850 Rockville, MD
	Tel	+1-301-977-3654
		Address record changed: 2012-02-04
Basic data	Employees	n. a.
		* Document for »About Section«: Expression Pathology Inc.. (1/11/11). "Press Release: Expression Pathology Provides Roche Its Liquid Tissue-SRM Protein Biomarker Assay Services in Drug Development". Rockville, MD.
		Record changed: 2012-02-14

More documents for Expression Pathology Inc. (EPI)

• [1] Expression Pathology Inc.. (2/13/12). "Press Release: Expression Pathology Collaborates on Liquid Tissue Personalized Medicine Assays in Lung Cancer Treatment". Rockville, MD....
• [2] Expression Pathology Inc.. (2/1/12). "Press Release: Expression Pathology Appoints New President and CEO". Rockville, MD....
• [3] Expression Pathology Inc.. (3/24/11). "Press Release: Expression Pathology Obtains Second U.S. Liquid Tissue Patent". Rockville, MD....
• [4] Expression Pathology Inc.. (2/1/11). "Press Release: Expression Pathology and Children’s Oncology Group to Measure IGF-1R Expression in Pediatric Clinical Rhabdomyosarcoma Tissue". Rockville, MD....
• [5] Expression Pathology Inc.. (1/11/11). "Press Release: Expression Pathology Provides Roche Its Liquid Tissue-SRM Protein Biomarker Assay Services in Drug Development". Rockville, MD....
• [6] Expression Pathology Inc.. (12/9/10). "Press Release: Flagship Partners with Expression Pathology to Combine Tissue Proteomics and Digital Pathology. Two Leading Companies Offer Clients Integrated Services for Digital Pathology and Quantitative Mass-spec...
• [7] Expression Pathology Inc.. (9/27/10). "Press Release: Expression Pathology’s Liquid Tissue Patent Issues in Japan". Rockville, MD....
• [8] Thermo Fisher Scientific Inc.. (5/20/10). Thermo Scientific Annual MS User’s Meeting & ASMS Customer Appreciation Event. [http://www.thermoscientific.com, 05/20/10]...
• [9] Expression Pathology Inc.. (5/4/10). "Press Release: Expression Pathology Collaborates with Toronto’s Sick Kids Hospital and University Health Network on New Mass Spec EGFR Test". Rockville, MD....
• [10] Expression Pathology Inc.. (11/17/09). "Press Release: Liquid Tissue Patent Licensed for Amyloidosis Proteomic Assay. Expression Pathology’s Method Enables Mass Spec Analysis of Amyloid Proteins in Microdissected FFPE Tissue". Rockville, MD....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.